Neuware - Nanoformulation Strategies for Cancer Treatment provides an up-to-date review on current developments and regulatory and clinical challenges in the field of nanopharmaceuticals and the effective treatment of diverse varieties of cancer. This important reference source is ideal for biomaterials scientists and pharmaceutical scientists working in the area of cancer diagnosis and therapy. Due to the high cost of traditional cancer treatment types, researchers have increasingly looked for new ways to augment the therapeutic performance of existing drug candidates. The use of nanotechnology-based approaches have gained significant momentum, thus leading to the launch of a series of new drug products. As nanopharmaceuticals improve the therapeutic performance of cancer therapy drugs, but also provide opportunities for site-specific drug targeting in tumors, this work is a welcomed resource on the topics discussed.

N� de r�f. du vendeur 9780128210956

Contacter le vendeur

Signaler cet article

D�tails bibliographiques

Titre: Nanoformulation Strategies for Cancer Treatment
�diteur: Elsevier Inc Nov 2020
Date de parution: 2020
Langue: anglais
ISBN � 10 chiffres: 0128210958
ISBN � 13 chiffres: 9780128210956
Reliure: Taschenbuch
�tat de l'article: Neu
Dimensions: 235�millim�tres de largeur par 191�millim�tres de hauteur par 21�millim�tres de profondeur
Poids: 690�grammes

A propos de ce titre

Synopsis

Nanoformulation Strategies for Cancer Treatment provides an up-to-date review on current developments and regulatory and clinical challenges in the field of nanopharmaceuticals and the effective treatment of diverse varieties of cancer. This important reference source is ideal for biomaterials scientists and pharmaceutical scientists working in the area of cancer diagnosis and therapy. Due to the high cost of traditional cancer treatment types, researchers have increasingly looked for new ways to augment the therapeutic performance of existing drug candidates. The use of nanotechnology-based approaches have gained significant momentum, thus leading to the launch of a series of new drug products.

As nanopharmaceuticals improve the therapeutic performance of cancer therapy drugs, but also provide opportunities for site-specific drug targeting in tumors, this work is a welcomed resource on the topics discussed.

� propos des auteurs

Sarwar Beg, PhD is currently serving as AMS-DBT Newton International Fellow at University of Central Lancashire, UK, and working in the area of glioblastoma research using targeted nanomedicines. He is also serving as the Assistant Professor at Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi. He has over a decade of teaching and research experience in the field of pharmaceutics and biopharmaceutics, especially in the development of novel and nanostructured drug delivery systems using Quality-by-Design paradigms with core expertise in computational pharmaceutics, experimental designs and multivariate statistical techniques. He has authored over 200 publications, 60 book chapters, 15 books, 03 Indian patent applications and H-Index of 40 with over 5400 citations to his credit.

Mahfoozur Rahman is an Assistant Professor at the Department of Pharmaceutical Sciences, Faculty of Health Science, Sam Higginbottom University of Agriculture, Technology & Sciences (SHUATS), Allahabad, India. He has authored more than 130 publications in peer-reviewed journals, 30 book chapters, seven books, and four articles in international magazines with various publishers. He has a Google Scholar h-index of 27 and over 1700 citations to his credit. He also serves on the editorial boards and as guest editor for several journals. He has received travel grants from various international congresses, such as IAPRD, MDS, Nano Today, KSN and WCN, on the basis of his research work and contribution in the field.

Dr. Hani Choudhry is an Associate Professor of Genomics and the Head of Cancer and Mutagenesis Unit at the King Fahd Center for Medical Research in King Abdulaziz University (KAU), Saudi Arabia. Dr. Choudhry completed his DPhil in Clinical Medicine in Prof. Sir Peter Ratcliffe (Nobel Laureate 2019)'s lab at the Wellcome Trust Center for Human Genetics, University of Oxford, UK. Dr. Choudhry has received a number of international and prestigious awards including two AACR Scholar-in-Training Award, the Susan G. Komen for the Cure Award, the ASHG/Charles J. Epstein Trainee Award for Excellence in Human Genetics Research (SF), the Professional Achievement Award and the National Cancer Research Institute (NCRI) Prize Award. He was awarded by the British Embassy and the UAE International Genetic Disorders Prevention Award- Scientific Excellence Award in GCC. Dr. Choudhry's current scientific interests focus on developing genomic technologies, and the integration of both clinical and pathological information with data generated from high-throughput molecular techniques. His work addresses the impact of genome and epigenome heterogeneity on the biology and clinical behaviour of diseases. In addition, he is leading a number of initiatives on artificial intelligence (AI) powered genome and drug discovery.

Eliana B. Souto is Habil. Professor from the Department of Pharmaceutical Technology of the Faculty of Pharmacy of University of Porto. Prof. Souto graduated in Pharmaceutical Sciences from University of Coimbra (2000), is holder of a master's in science degree in Pharmaceutical Technology from University of Porto (2002), and PhD in Pharmaceutical Nanotechnology and Biopharmaceutics from the Institut fuer Pharmazie der Freie Universitaet Berlin, Germany (2005). Her research lines include the design, development, and characterization of new drug delivery systems to overcome biological barriers. Prof. Souto serves as Associate Editor, member of the Editorial Board, and Reviewer of several international scientific journals and has published more than 500 works (original and review papers, books and book chapters) in the field of nanosciences and nanomedicine. Prof. Souto also acts as independent expert for several national, European and international funding agencies, and as consultant for pharmaceutical industry.

Professor Farhan Jalees Ahmad, is currently a Professor, School of Pharmaceutical Education & Research, and Dean, Interdisciplinary Sciences, Jamia Hamdard, New Delhi, India is an internationally known researcher in the area of Pharmaceutical Sciences. Having obtained his degree in M.Pharma and Ph.D (Medicine) from Jamia Hamdard, he continues to teach and leads a very productive research group which has been funded extensively by National and international funding agencies. He has earned many accolades including Young Scientist Fast Track from DST, Scientist of the Year-2005 from NESA, UGC Research Award 2011, Bharat Jyoti Award 2011, Pharma Ratan 2017, ABAP Senior Scientist Award 2017 and also prizes in scientific poster session in National Pharmacy Symposium. He has a US patent, Two PCT and 24 Indian patents to his name. He has published more than 300 research and review papers, 12 Book chapters, 9 books with a total citation of 9000, H Index of 44 and i-10 index of 200and attended many national and international conferences for presentation of research papers.Professor Farhan Jalees Ahmad, is currently a Professor, School of Pharmaceutical Education & Research, and Dean, Interdisciplinary Sciences, Jamia Hamdard, New Delhi, India is an internationally known researcher in the area of Pharmaceutical Sciences. Having obtained his degree in M.Pharma and Ph.D (Medicine) from Jamia Hamdard, he continues to teach and leads a very productive research group which has been funded extensively by National and international funding agencies. He has earned many accolades including Young Scientist Fast Track from DST, Scientist of the Year-2005 from NESA, UGC Research Award 2011, Bharat Jyoti Award 2011, Pharma Ratan 2017, ABAP Senior Scientist Award 2017 and also prizes in scientific poster session in National Pharmacy Symposium. He has a US patent, Two PCT and 24 Indian patents to his name. He has published more than 300 research and review papers, 12 Book chapters, 9 books with a total citation of 9000, H Index of 44 and i-10 index of 200and attended many national and international conferences for presentation of research papers.

Les informations fournies dans la section � A propos du livre � peuvent faire r�f�rence � une autre �dition de ce titre.

Description de la librairie

Das Unternehmen AHA-BUCH GmbH: Seit der Gr�ndung von AHA-BUCH im Juli 2005 ist unser Hauptziel, zufriedenen Kunden so schnell und so preisg�nstig wie m�glich ihren B�cherwunsch zu erf�llen. Unsere Firma besch�ftigt 16 Mitarbeiter, die nur ein Ziel kennen: den Kunden und seine W�nsche! Auf �ber 3700 m2 Fl�che haben wir �ber 100.000 B�cher, Modernes Antiquariat und Spiele auf Lager.

Visitez la page d�accueil du vendeur

Informations commerciales relatives au vendeur

AHA-BUCH GmbH
Garlebsen 48, Einbeck, 37574, Germany

Conditions de vente et de livraison

Conditions g�n�rales de vente

Conditions g�n�rales et informations client

I. Conditions g�n�rales

� 1 Dispositions de base

(1) Les conditions g�n�rales suivantes s?appliquent � tous les contrats que vous concluez avec nous en tant que fournisseur (AHA-BUCH GmbH) via les plateformes Internet AbeBooks et/ou ZVAB. Sauf accord contraire, l?inclusion de l?une de vos propres conditions g�n�rales que vous utilisez sera contest�e

(2) Un consommateur au sens des r�glements suivants est toute personne physique qui conclut une transact...

Pour plus d'information

Droit de r�tractation

Si vous �tes un consommateur, vous pouvez exercer votre droit de r�tractation sur le contrat conform�ment � ce qui suit. Le mot � consommateur � d�signe toute personne physique agissant � des fins qui n'entrent pas dans le cadre de son activit� commerciale, artisanale ou professionnelle.

Informations concernant le droit de r�tractation

Droit statutaire de r�tractation

Vous avez le droit d'exercer votre droit de r�tractation sur ce contrat dans les 14 jours sans donner de raison.

Le d�lai de r�tractation expirera au bout de 14 jours � compter du jour o� vous-m�me, ou un tiers autre que le transporteur et d�sign� par vous, prendrez physiquement possession de la derni�re marchandise, du dernier lot ou de la derni�re pi�ce.

Pour exercer votre droit de r�tractation, remplissez �lectroniquement et envoyez une d�claration claire sur notre site Web, sous � Vos achats � dans � Votre compte �. Nous vous communiquerons sans d�lai un accus� de r�ception de cette r�tractation sur un support durable (par exemple, par e-mail).

Pour respecter le d�lai de r�tractation, il vous suffit d'envoyer votre message concernant l'exercice de votre droit de r�tractation avant l'expiration du d�lai de r�tractation.

Effets de la r�tractation

Si vous exercez votre droit de r�tractation sur ce contrat, nous vous rembourserons tous les paiements que vous avez effectu�s, y compris les frais de livraison (� l'exception des frais suppl�mentaires r�sultant du choix d'un mode de livraison autre que le type de livraison standard le moins cher que nous proposons).

Nous pouvons d�duire du remboursement la perte de valeur de toute marchandise livr�e, si la perte est le r�sultat d'une manipulation inutile de votre part.

Nous effectuerons le remboursement dans les meilleurs d�lais, et au plus tard 14 jours apr�s le jour o� nous aurons �t� inform�s de votre d�cision d'exercer votre droit de r�tractation sur ce contrat.

Nous effectuerons le remboursement en utilisant le m�me moyen de paiement que celui que vous avez utilis� pour la transaction initiale, sauf si vous en avez express�ment convenu autrement ; en tout �tat de cause, aucuns frais ne vous seront factur�s � la suite d'un tel remboursement.

Nous pouvons suspendre le remboursement jusqu'� ce que nous ayons re�u les marchandises ou que vous ayez fourni la preuve que vous avez renvoy� les marchandises, en fonction de la premi�re �ventualit�.

Vous devez renvoyer les marchandises ou les remettre � AHA-BUCH GmbH, Einbeck, Germany, sans retard injustifi� et, en tout �tat de cause, au plus tard 14 jours � compter du jour o� vous nous avez communiqu� votre d�cision de r�tractation du pr�sent contrat. Le d�lai est respect� si vous renvoyez les marchandises avant l'expiration du d�lai de 14 jours. Vous devrez prendre en charge les frais directs du renvoi des marchandises. Vous n'�tes responsable que de toute diminution de valeur des marchandises r�sultant d'une manipulation autre que celle n�cessaire pour �tablir la nature, les caract�ristiques et le fonctionnement des marchandises.

Exceptions au droit de r�tractation

Le droit de r�tractation ne s'applique pas � ce qui suit :

Distribution de journaux, de revues ou de magazines, � l'exception des contrats d'abonnement ; et
Fourniture d'un contenu num�rique qui n'est pas fourni sur un support mat�riel (par exemple, sur un CD ou un DVD) si vous avez accept�, lors de votre commande, que nous puissions commencer � le livrer et que vous ne puissiez pas exercer votre droit de r�tractation une fois la livraison commenc�e.

Conditions d'exp�dition

Nous exp�dions votre commande apr�s les avoir re�ues
pour les articles disponibles au plus tard 24 heures,
pour les articles avec un approvisionnement de nuit au plus tard 48 heures.
Dans le cas o� nous devons commander un article aupr�s de notre fournisseur, notre d�lai d’exp�dition d�pend de la date de r�ception des articles, mais les articles seront exp�di�s le jour m�me.

Notre objectif est d’envoyer les articles command�s de la mani�re la plus rapide, mais aussi la plus efficace et la plus s�curis�e � nos clients.

Frais d'exp�dition de Allemagne�vers�Etats-Unis

Frais d'exp�dition de Allemagne�vers�Etats-Unis
Quantit� command�e	30 � 40 jours ouvr�s	7 � 14 jours ouvr�s
Premier article	EUR 63.45	EUR 73.45

Les d�lais de livraison sont fix�s par les vendeurs et varient en fonction du transporteur et du lieu. Les commandes transitant par les douanes peuvent �tre retard�es et les acheteurs sont responsables de tous les droits ou frais associ�s. Les vendeurs peuvent vous contacter au sujet de frais suppl�mentaires afin de couvrir toute augmentation des co�ts d'exp�dition de vos articles.

Informations vendeur d�taill�es